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Introduction: building capacity and expanding 
genomics research in Africa
The 6th Meeting of the African Society of Human Genetics 
(AfSHG) and the 14th Southern African Society of Human 
Genetics (SASHG) Congress were held jointly in Cape 
Town. These meetings overlapped with the 2011 Inter­
national Society for Computational Biology and African 
Society  for  Bioinformatics  and  Computational  Biology 
Conferences, thereby appealing to a wide array of bio­
medical researchers. The AfSHG and SASHG meetings 
were held on the tail of a meeting discussing the new 
initiative jointly funded by NIH and The Wellcome Trust, 
‘Human Heredity and Health in Africa (H3Africa)’, and 
the theme, ‘Building Capacity for Genomic and Trans­
lational  Research  in  Africa’,  complemented  the  other 
meetings.
The meeting emphasized the importance of genomics 
studies  in  Africa  for  increasing  our  understanding  of 
human  evolutionary  history  and  the  genetic  bases  of 
disease susceptibility and drug response. The intro  duc­
tory talks made by the presidents of the two organizing 
societies, Charles Rotimi (AfSHG) and Michele Ramsay 
(SASHG), discussed the crucial role that genomic studies 
in  Africa  should  play  in  helping  us  to  understand  the 
relationship  between  human  diversity  and  disease  pre­
disposition, and how it is imperative to build capacity on 
the continent to make such studies possible. The building 
of  both  human  and  physical  capacities  provided  a 
common thread throughout many of the talks. Represen­
tatives  of  several  genetics  and  genomics  societies  in 
Africa  presented  overviews  of  how  their  organizations 
facilitate research collaborations both amongst African 
scientists and between African scientists and the inter­
national community, thereby increasing the capacity for 
genomics  research  in  Africa.  The  speakers  included 
Charles  Rotimi  (National  Human  Genome  Research 
Institute, USA (NHGRI)), Michele Ramsay (University of 
Witwatersrand,  SA),  Amal  M  Mohamed  (National 
Society of Human Genetics, National Research Centre, 
Egypt)  and  Ambroise  Wonkam  (Cameroon  Society  of 
Human Genetics, University of Yaounde, Cameroon, and 
University of Cape Town, SA). Sir Mark Walport (The 
Wellcome Trust, UK) discussed the role of The Wellcome 
Trust, providing both historical context and an overview 
of modern funding initiatives in Africa. Here, we cover 
the  main  themes  of  the  meeting  and  describe  how 
research in Africa can inform the biomedical community 
on the role of genetics and genomes in understanding 
many diseases.
Human genetic diversity and history
The  opening  talks  of  the  meeting  focused  on  how  the 
information contained in our genomes provides key data 
that  can  be  used  to  unravel  our  histories.  This  theme 
began  with  Sydney  Brenner  (Janelia  Farms,  Howard 
Hughes Medical Institute, USA) who discussed ‘Reading 
the Human Genome’ in an almost literal sense (that is, 
from one end of chromosome 1 to the opposite end of 
the  X  chromosome).  Brenner  argued  that  the  human 
genome  contains  extensive  information  about  the 
historical and biological properties of our species, and 
that even if we read the ‘Cliffnote’ version of the genome, 
the exons only, we can extract an enormous amount of 
information  that  could  be  translated  into  genomic 
medicine.  Of  particular  note  were  his  final  comments; 
Brenner argued not for bench­to­bedside medicine, but 
rather for bedside­to­bench medicine, making use of the 
extensive  genetic  data  currently  available  from  the 
genetic text.
Several  additional  talks  addressed  the  evolution  of 
human populations (especially within Africa) and their 
cultures and languages from multiple perspectives. Sarah 
Tishkoff  (University  of  Pennsylvania,  USA),  Daniel 
Shriner (NHGRI), Christopher Gagneaux (University of 
California,  San  Francisco,  USA)  and  Brenna  Henn 
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whereas John Parkington (University of Cape Town, SA) 
and Shomarka Keita (Howard University, USA) approached 
these  topics  from  archaeological  and  anthropological 
perspectives, respectively. These talks were of note in that 
it became obvious that differing approaches can lead to a 
variety of conclusions that will require integration and 
resolution.
Genomic research: translational limits and 
resource limitations in Africa
Eric Green (NHGRI) opened a session on public health 
genetics  with  an  overview  of  his  institutes’  research 
portfolio, importantly cautioning that work being done 
today will require years to translate into clinical practice. 
This adjustment of expectations is arguably amongst the 
most  important  thing  genomicists  can  do  to  ensure 
continued  research.  Edison  Liu  (Genome  Institute  of 
Singapore, Singapore) followed by presenting the reasons 
for  prioritizing  genomics  research  in  resource­limited 
environments,  arguing  that  such  research  can  provide 
bases for health policy and human sustainability and that 
it  can  be  of  top  quality.  Extending  the  idea  of  how 
research can impact health policy requires the develop­
ment of appropriate infrastructures, both intellectual and 
technological.  The  session  on  networks,  infrastructure 
and training began with a talk by Dominic Kwiatkowski 
(Oxford University, UK), who laid out key issues relating 
to  the  use  of  the  MalariaGen  network  as  a  model  for 
understanding the evolution of malaria as a disease, from 
the  perspective  of  both  host  and  parasite.  Doris 
Schroeder  (University  of  Central  Lancashire,  UK) 
empha  sized that the development of successful research 
and  the  anticipated  successes  that  are  eventually 
translated need to be shared with the local populations 
and researchers that made them possible, although the 
exact  parameters  are  not  presently  defined,  either 
ethically or legally in human genomics research. Arnold 
Christiansen  (University  of  Witwatersrand,  SA)  gave  a 
presentation  that  dealt  with  the  problem  of  reduced 
funding  for  medical  genetics  and  how  it  has  adversely 
impacted aspects of medical care in South Africa, and 
Pasquale de Blasio (BioRep SRL, Italy) led a discussion on 
the steps and resources needed to develop crucial bio­
banking facilities on the African continent. Both of these 
talks raised the issue of limited resources in Africa for 
both research and medicine, and emphasized the need to 
increase  the  funding  and  thus  capacity  for  genomics 
research on the continent.
Genomic medicine: current applications
In  a  session  focusing  on  molecular  pathology,  Griffin 
Rodgers (National Institute of Diabetes and Digestive and 
Kidney Disease, USA) gave a presentation that focused 
on treatments for sickle cell disease, including allogenic 
transplantation.  This  was  followed  by  a  talk  on  the 
genetics of type 2 diabetes mellitus by Mark McCarthy 
(Oxford University, UK), who reviewed the identification 
of  more  than  40  genes  that  are  associated  with  the 
disease. Most previous studies have focused on popu  la­
tions of European ancestry and many of the identified 
genes are involved in reduced beta cell function and cell 
cycling.  Expansion  to  African  populations  will  be 
essential  for  fine­mapping  and  to  identify  disease  risk 
variants that may be geographically restricted to Africa.
Several  talks  focused  on  the  theme  of  translational 
research  and  pharmacogenetics.  Howard  McLeod 
(Univer  sity  of  North  Carolina  at  Chapel  Hill,  USA) 
discussed the importance of how drugs are prescribed: 
drug familiarity being a major factor in wealthier nations 
where a different drug is substituted if the first­prescribed 
drug is ineffective. This luxury does not exist in lower and 
middle income countries (LMICs) where much shorter 
drug lists exist. In LMICs, it is important to have an idea 
of what will work before choosing a drug, and this may be 
accomplished  by  identifying  and  characterizing  the 
distribution  of  polymorphisms  that  affect  drug 
metabolism. McLeod proposed that this can be achieved 
with  extensive  genetic  characterization  across  LMICs 
and  by  applying  pharmacogenetic  principles  in  a  way 
that, although less than perfect, is a substantial improve­
ment over current practice in terms of both treatment 
outcome and cost.
Michael Hayden (University of British Columbia, Van­
couver, Canada) followed with a discussion of analyses of 
patients with extreme drug­response phenotypes, which 
aim  to  identify  factors  that  are  associated  with  large 
effects. This approach contrasts with modern genome­
wide  association  studies  of  common  traits,  which 
typically  identify  variants  of  small  effect,  and  can  lead 
quickly to clinical applications. Among other examples, 
Hayden discussed the adverse effects of cisplatin, describ­
ing how variants at two genes (Catechol-O-methyltrans-
ferase  (COMT)  and  Thiopurine  S-methyltransferase 
(TPMT))  are  associated  with  most  cases  of  cisplatin­
related  deafness  in  children.  This  study  involved  fewer 
than  200  children,  arguing  for  the  role  of  large­effect 
genes  in  pharmacogenetics.  These  studies  demonstrate 
the utility of genetics in medical care, even in resource­
limited environments.
John Burns (University of Newcastle, UK) spoke about 
targeted approaches used to study specific diseases, many 
of which are caused by single genes with large effects, and 
Olufunmilayo  Olopade  (University  of  Chicago,  USA) 
discussed  how  genetic  risk  factors  that  are  associated 
with breast and ovarian cancers in populations of Euro­
pean descent do not necessarily replicate in populations 
of African descent because of, for example, the different 
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populations.
Taken together, these talks demonstrated not only that 
genes of potential clinical importance can be found but 
also that, even at present, some of them may be translated 
into  practice.  Nevertheless,  transferability  among 
populations  is  still  a  substantial  issue  that  requires 
intensive study.
Infrastructure and educational development in 
Africa
Abdallah Daar (University of Toronto, Canada) discussed 
the  needs  for  and  challenges  in  the  development  of 
African biorepositories. He argued that the main con  su­
mers of genomics in the future will be from LMICs, and 
therefore  that  these  countries  should  be  developing 
resources  that  are  currently  limited,  including  basic 
research capacity, basic financial and health­care systems, 
and regulatory infrastructures that can provide guidelines 
for appropriate access to samples that will ensure local 
benefit.
Patricia  Marshall  (Case  Western  University,  USA) 
followed with a discussion of how education can affect 
the answer to the question ‘What were you told about the 
purpose of this study?’. As might be expected, education 
was  crucial  to  achieving  an  understanding  of  research 
goals, but its effect was modified by a variety of factors, 
including the medium used to educate and the perceived 
severity of the disease.
The  final  topic  covered  at  the  meeting  was  the 
development and use of new technologies and method­
olo  gies  to  understand  biological  and  biomedical  ques­
tions.  Jason  Moore  (Dartmouth  College,  USA)  intro­
duced the concept of epistasis or gene­gene interaction 
and how it is important for studies of human phenotypes. 
He emphasized that our ability to understand the genetic 
basis  of  common  disease  is  tied  to  the  underlying 
complexity of the genetic models, and that we need to 
expand our capacity to develop models beyond those that 
are mired solely in single­gene association. He described 
a  method  that  uses  dimensionality  reduction,  called 
MDR,  to  address  this  issue.  David  Bentley  (Illumina) 
discussed the development of next generation sequencing 
technologies and how these have been used to identify 
previously  unknown  mutations.  He  presented  several 
cases in which high­throughput sequence data generation 
allowed  the  identification  of  previously  unknown 
mutations  that  cause  disease,  making  the  case  that 
technology  will  provide  a  permissive  environment  for 
disease gene discovery.
Genomic research in Africa: opportunities and 
challenges
The focus of this meeting was on building capacity for 
genomics  research  in  Africa  to  better  understand, 
prevent and treat human disease, and to better under­
stand human history and evolution. The speakers made 
key  points  about  how  researchers  and  clinicians  have 
worked together to translate a few genomic discoveries 
into health­care practice, but reported that progress is 
mostly being made in the developed world. Nevertheless, 
the needs and opportunities in LMICs, and in Africa in 
particular  because  of  its  unique  position  in  human 
evolution,  are  substantial.  Speakers  repeatedly  empha­
sized the requirement to build research capacity within 
Africa for genomics, both by building physical research 
infrastructure  and  by  training  and  retaining  African 
scientists. New approaches, either under development or 
already in practice, that were presented at the meeting 
provided insight into how genomics research might begin 
to meet important goals on the African continent.
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